Top Midday Gainers

MT Newswires Live

21 hours ago

Cementos Pacasmayo (CPAC) said Tuesday that a Swiss company, Holcim, has signed an agreement to acquire Inversiones Aspi from the Hochschild Group, which controls 50.01% in Cementos.

Shares of Cementos surged 47% as intraday trading volume advanced to nearly 3.01 million from a daily average of over 17,000.

B. Riley Financial (RILY) shares soared 37% amid heavy trading after the company reported overnight a swing to Q2 earnings amid a year-over-year increase in revenue.

Intraday trading volume climbed to more than 9.88 million shares from a daily average of around 699,000.

Monte Rosa Therapeutics (GLUE) said Tuesday that interim data from its ongoing phase 1/2 study of its investigational drug MRT-2359 combined with enzalutamide showed a 64% overall disease control rate in certain patients with metastatic castration-resistant prostate cancer.

Wedbush lifted Monte Rosa's price target to $26 from $19 while maintaining the shares' outperform rating

Shares of Monte Rosa jumped 9.8%, with intraday trading volume at over 1.50 million compared with a daily average of about 1.05 million.

Price: 10.28, Change: +3.29, Percent Change: +47.10

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2592606931"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2592606931\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2592606931?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-17 02:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592606931","market":"hk","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> Cementos Pacasmayo (CPAC) said Tuesday that a Swiss company, Holcim, has signed an agreement to acquire Inversiones Aspi from the Hochschild Group, which controls 50.01% in Cementos.</p><p>Shares of Cementos surged 47% as intraday trading volume advanced to nearly 3.01 million from a daily average of over 17,000.</p><p><a href=\"https://laohu8.com/S/RILY\">B. Riley</a> Financial (RILY) shares soared 37% amid heavy trading after the company reported overnight a swing to Q2 earnings amid a year-over-year increase in revenue.</p><p>Intraday trading volume climbed to more than 9.88 million shares from a daily average of around 699,000.</p><p><a href=\"https://laohu8.com/S/GLUE\">Monte Rosa Therapeutics</a> (GLUE) said Tuesday that interim data from its ongoing phase 1/2 study of its investigational drug MRT-2359 combined with enzalutamide showed a 64% overall disease control rate in certain patients with metastatic castration-resistant prostate cancer.</p><p>Wedbush lifted Monte Rosa's price target to $26 from $19 while maintaining the shares' outperform rating</p><p>Shares of Monte Rosa jumped 9.8%, with intraday trading volume at over 1.50 million compared with a daily average of about 1.05 million.</p><p>Price: 10.28, Change: +3.29, Percent Change: +47.10</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-17 02:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Cementos Pacasmayo (CPAC) said Tuesday that a Swiss company, Holcim, has signed an agreement to acquire Inversiones Aspi from the Hochschild Group, which controls 50.01% in Cementos.</p><p>Shares of Cementos surged 47% as intraday trading volume advanced to nearly 3.01 million from a daily average of over 17,000.</p><p><a href=\"https://laohu8.com/S/RILY\">B. Riley</a> Financial (RILY) shares soared 37% amid heavy trading after the company reported overnight a swing to Q2 earnings amid a year-over-year increase in revenue.</p><p>Intraday trading volume climbed to more than 9.88 million shares from a daily average of around 699,000.</p><p><a href=\"https://laohu8.com/S/GLUE\">Monte Rosa Therapeutics</a> (GLUE) said Tuesday that interim data from its ongoing phase 1/2 study of its investigational drug MRT-2359 combined with enzalutamide showed a 64% overall disease control rate in certain patients with metastatic castration-resistant prostate cancer.</p><p>Wedbush lifted Monte Rosa's price target to $26 from $19 while maintaining the shares' outperform rating</p><p>Shares of Monte Rosa jumped 9.8%, with intraday trading volume at over 1.50 million compared with a daily average of about 1.05 million.</p><p>Price: 10.28, Change: +3.29, Percent Change: +47.10</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2592606931","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592606931","pubTimestamp":1765908646,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cementos Pacasmayo  said Tuesday that a Swiss company, Holcim, has signed an agreement to acquire Inversiones Aspi from the Hochschild Group, which controls 50.01% in Cementos.Shares of Cementos surged 47% as intraday trading volume advanced to nearly 3.01 million from a daily average of over 17,000.B. Riley Financial  shares soared 37% amid heavy trading after the company reported overnight a swing to Q2 earnings amid a year-over-year increase in revenue.Intraday trading volume climbed to more than 9.88 million shares from a daily average of around 699,000.Monte Rosa Therapeutics  said Tuesday that interim data from its ongoing phase 1/2 study of its investigational drug MRT-2359 combined with enzalutamide showed a 64% overall disease control rate in certain patients with metastatic castration-resistant prostate cancer.Wedbush lifted Monte Rosa's price target to $26 from $19 while maintaining the shares' outperform ratingShares of Monte Rosa jumped 9.8%, with intraday trading volume a","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IE0031619046.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) INC","RILY":"B. Riley Financial, Inc.","CPAC":"Cementos Pacasmayo S.A.A.","BK4127":"投资银行业与经纪业","GLUE":"Monte Rosa Therapeutics","IE00B7SZL793.SGD":"Legg Mason Royce - US Small Cap Opportunity A Acc SGD-H","IE00B19Z4B17.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) ACC","IE00B66KJ199.SGD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY  \" A\" (SGD) ACC","BK4539":"次新股","BK4011":"建筑材料"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLUE":1,"CPAC":1,"RILY":1},"content_text":"Cementos Pacasmayo (CPAC) said Tuesday that a Swiss company, Holcim, has signed an agreement to acquire Inversiones Aspi from the Hochschild Group, which controls 50.01% in Cementos.Shares of Cementos surged 47% as intraday trading volume advanced to nearly 3.01 million from a daily average of over 17,000.B. Riley Financial (RILY) shares soared 37% amid heavy trading after the company reported overnight a swing to Q2 earnings amid a year-over-year increase in revenue.Intraday trading volume climbed to more than 9.88 million shares from a daily average of around 699,000.Monte Rosa Therapeutics (GLUE) said Tuesday that interim data from its ongoing phase 1/2 study of its investigational drug MRT-2359 combined with enzalutamide showed a 64% overall disease control rate in certain patients with metastatic castration-resistant prostate cancer.Wedbush lifted Monte Rosa's price target to $26 from $19 while maintaining the shares' outperform ratingShares of Monte Rosa jumped 9.8%, with intraday trading volume at over 1.50 million compared with a daily average of about 1.05 million.Price: 10.28, Change: +3.29, Percent Change: +47.10","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}